Literature DB >> 9797131

p73, a gene related to p53, is not mutated in esophageal carcinomas.

Y Nimura1, M Mihara, S Ichimiya, S Sakiyama, N Seki, M Ohira, N Nomura, M Fujimori, W Adachi, J Amano, M He, Y M Ping, A Nakagawara.   

Abstract

A novel gene, termed p73, encodes a protein with a significant homology to p53 and has been mapped at chromosome 1p36.3, which is a locus of multiple suppressor genes for tumors including neuroblastoma and other cancers. Since the 1p36 locus is reported to be deleted and p53 is frequently mutated in esophageal carcinomas, we examined loss of heterozygosity (LOH) and mutation of the p73 gene in 48 untreated esophageal tumors, as well as mRNA expression in 8 tumors. We screened the P1 genomic library to obtain a P1 clone containing the p73 gene and found a polymorphic short tandem CT repeat site at intron 9. Intragenic sequences for 14 PCR primer sets and a primer pair flanking the repeat were also determined for the analysis of PCR single-strand conformation polymorphism (SSCP) and LOH studies, respectively. Expression of p73 mRNA was detectable but at low levels in all 8 tumor tissues by reverse transcriptase PCR. We did not find any type of mutation other than polymorphisms in the 48 esophageal carcinomas, though aberration of the p53 gene on the PCR-SSCP gels was observed in 15 of 38 (39%) tumors of the same set. In addition, LOH for p73 was found in only 2 of 25 (8%) tumors. These results suggest that, at least in esophageal carcinomas, allelic loss or mutation of p73 may not be a main genetic event for the tumorigenesis as it is with p53.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797131     DOI: 10.1002/(sici)1097-0215(19981109)78:4<437::aid-ijc8>3.0.co;2-v

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  DeltaNp73beta is active in transactivation and growth suppression.

Authors:  Gang Liu; Susan Nozell; Hui Xiao; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

2.  p73 G4C14 to A4T14 polymorphism is associated with colorectal cancer risk and survival.

Authors:  Kyung-Eun Lee; Young-Seoub Hong; Byoung-Gwon Kim; Na-Young Kim; Kyoung-Mu Lee; Jong-Young Kwak; Mee-Sook Roh
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

3.  Association of a p73 exon 2 GC/AT polymorphism with colorectal cancer risk and survival in Tunisian patients.

Authors:  Amira Toumi Arfaoui; Lilia Ben Mahmoud Kriaa; Olfa El Amine El Hadj; Majid A Ben Hmida; Myriam Khiari; T Khalfallah; Lasaad Gharbi; Sabeh Mzabi; Sadaa Bouraoui
Journal:  Virchows Arch       Date:  2010-07-20       Impact factor: 4.064

4.  Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck.

Authors:  Yang Zhang; Erich M Sturgis; Zhigang Huang; Mark E Zafereo; Qingyi Wei; Guojun Li
Journal:  Cancer       Date:  2011-06-29       Impact factor: 6.860

Review 5.  From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.

Authors:  Ravindran Caspa Gokulan; Monica T Garcia-Buitrago; Alexander I Zaika
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

6.  A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.

Authors:  C Gaiddon; M Lokshin; J Ahn; T Zhang; C Prives
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

7.  Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer: a case control study in a northern Indian population.

Authors:  Meenakshi Umar; Rohit Upadhyay; Rohini Khurana; Shaleen Kumar; Uday Chand Ghoshal; Balraj Mittal
Journal:  Mol Biol Rep       Date:  2011-05-15       Impact factor: 2.316

8.  p73beta inhibits transcriptional activities of enhancer I and X promoter in hepatitis B virus more efficiently than p73alpha.

Authors:  Zhen-Hua Xu; Mu-Jun Zhao; Tsai-Ping Li
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

9.  Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients.

Authors:  L Thorstensen; H Qvist; S Heim; G J Liefers; J M Nesland; K E Giercksky; R A Lothe
Journal:  Neoplasia       Date:  2000 Nov-Dec       Impact factor: 5.715

10.  p73 overexpression and nuclear accumulation in hepatitis C virus-associated hepatocellular carcinoma.

Authors:  Romy Zemel; Claud Koren; Larisa Bachmatove; Smadar Avigad; Ella Kaganovsky; Elimelech Okon; Ziv Ben-Ari; Franklin Grief; Merav Ben-Yehoyada; Yosef Shaul; Ran Tur-Kaspa
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.